Tel Aviv Medical Center, Pain Institute
Center for Medicinal Cannabis Research and Treatment
Cannabis has been used by humanity for thousands of years and by medical community for centuries, however substantial progress in biomedical research to better understand the mechanism only began with discovery of the chemical structure of tetrahydrocannabinol (THC) and additional cannabinoids in the 1970s.
The analgesic effect of cannabinoids has been demonstrated by extensive preclinical research, but in-depth human studies have been less consistent.
The purpose of the Center is to:
Internationally coordinate rigorous scientific studies to assess the safety and efficacy of cannabis and cannabis compounds for treating medical condition
Provide guidelines for treating medical conditions with cannabis.
Collaboration and interaction with MOH and European agencies, regulatory agencies and Tel Aviv University
The Centre will draw on local and international researchers to advance our formal understanding of medicinal cannabis, monitor the clinical trials, educate the community and help stakeholders navigate regulatory processes.
This purpose of the Center is to be involved involve medicinal in preclinical research, early human testing and clinical trials in patients, with the overall aim to optimize and introduce safe and effective cannabinoid therapeutics into mainstream medicine nationally and internationally.
The center will conduct and coordinate research on cannabis and its biological effects toward commercial applications.
To promote cooperation with the pharmaceutical industry with the aim of converting scientific achievements in the field of cannabis and cannabinoids into potential commercial value.
Promoting International school, joint seminars and workshops and international meetings. The center will bring together researchers and industry from Israel, and abroad.
Leading global research and an evidence-based approach to the safe and effective use of cannabis in medicine.